Piero Portincasa
Piero Portincasa
Professore di Medicina Interna Università di Bari
Email verificata su uniba.it
Titolo
Citata da
Citata da
Anno
Cholesterol gallstone disease
P Portincasa, A Moschetta, G Palasciano
The Lancet 368 (9531), 230-239, 2006
6772006
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.
A Parodi, A Colecchia, PS Orsola-Malpighi, D Festi, F Perri
Aliment Pharmacol Ther 29 (1), 1-49, 2009
3802009
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ...
Nature genetics 42 (8), 658-660, 2010
3712010
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis
I Grattagliano, VO Palmieri, P Portincasa, A Moschetta, G Palasciano
The Journal of nutritional biochemistry 19 (8), 491-504, 2008
3202008
Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus
M Minagawa, M Makuuchi
World journal of gastroenterology: WJG 12 (47), 7561, 2006
2792006
Nonalcoholic fatty liver disease
M Krawczyk, L Bonfrate, P Portincasa
Best practice & research Clinical gastroenterology 24 (5), 695-708, 2010
2242010
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial
C Loguercio, P Andreone, C Brisc, MC Brisc, E Bugianesi, M Chiaramonte, ...
Free Radical Biology and Medicine 52 (9), 1658-1665, 2012
1892012
Biochemical mechanisms in drug-induced liver injury: certainties and doubts
I Grattagliano, L Bonfrate, CV Diogo, HH Wang, DQH Wang, P Portincasa
World journal of gastroenterology: WJG 15 (39), 4865, 2009
1892009
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones
HH Wang, P Portincasa, N Mendez–Sanchez, M Uribe, DQH Wang
Gastroenterology 134 (7), 2101-2110, 2008
1812008
Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome
VO Palmieri, I Grattagliano, P Portincasa, G Palasciano
The Journal of nutrition 136 (12), 3022-3026, 2006
1752006
Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index.
G Palasciano, P Portincasa, V Vinciguerra, A Velardi, S Tardi, ...
American Journal of Gastroenterology 84 (11), 1989
1661989
Mitochondrial dysfunction in rat with nonalcoholic fatty liver: Involvement of complex I, reactive oxygen species and cardiolipin
G Petrosillo, P Portincasa, I Grattagliano, G Casanova, M Matera, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1767 (10), 1260-1267, 2007
1642007
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ...
Nature communications 6 (1), 1-11, 2015
1592015
EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones
F Lammert, M Acalovschi, G Ercolani, KJ van Erpecum, K Gurusamy, ...
1482016
Coordinate regulation of gallbladder motor function in the gut‐liver axis
P Portincasa, A Di Ciaula, HH Wang, G Palasciano, KJ Van Erpecum, ...
Hepatology 47 (6), 2112-2126, 2008
1352008
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management
P Portincasa, I Grattagliano, VO Palmieri, G Palasciano
Clinical biochemistry 38 (3), 203-217, 2005
1322005
Survival and Metabolic Activity of Microencapsulated Bifidobacterium longum in Stirred Yogurt
K Adhikari, A Mustapha, IU Grün
Journal of Food Science 68 (1), 275-280, 2003
1322003
Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research
S Russmann, I Grattagliano, P Portincasa, VO Palmieri, G Palasciano
Current medicinal chemistry 13 (27), 3351-3357, 2006
1312006
Gallstones
F Lammert, K Gurusamy, CW Ko, JF Miquel, N Méndez-Sánchez, ...
Nature reviews Disease primers 2 (1), 1-17, 2016
1282016
Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease–a double‐blind, randomised, placebo …
A Tursi, G Brandimarte, W Elisei, M Picchio, G Forti, G Pianese, S Rodino, ...
Alimentary pharmacology & therapeutics 38 (7), 741-751, 2013
1232013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20